Use of positron emission tomography to study tumors in vivo

Molecular Medicine Today

Volumn 2, Issue 12, 1996, Pages 528-534

  Hamberg, Leena M ^a   Hunter, George J ^a   Fischman, Alan J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED EMISSION TOMOGRAPHY; FORECASTING; HUMAN; NEOPLASM; RADIOGRAPHY; REVIEW;

FORECASTING; HUMANS; NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030332057     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)81457-8     Document Type: Review

References (32)

1. Ter-Pogassian, M.M. (1992) The origins of positron emission tomography, Semin. Nucl. Med. XXII, 140-149
2. Brownell, G.L. and Sweet, W.H. (1953) Localization of brain tumors with positron emitters, Nucleonics 11, 40-45
3. Rankowitz, S., Robertson, J.S. and Higgenbothman, W.A. (1962) Positron scanner for locating brain tumors, in Edited Proc. IRE Int. Conv. Rec. New York (Part 9), 49-56
4. Hawkins, R.A. et al. (1992) The role of positron emission tomography in oncology and other whole-body applications, Semin. Nucl. Med. XXII, 268-284
5. Rege, S.D. et al. (1993) Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose, Cancer 72, 82-90
6. Sorenson, J.A. and Phelps, M.E. (1987) Physics in Nuclear Medicine, W.B. Saunders Company
7. Alpert, N.M., Bradshaw, J.F., Kennedy, D. and Correia, J.A. (1990) The principal axes transformation - a method for image registration, J. Nucl. Med. 31, 1717-1722
8. Woods, R.P., Mazziotta, J.C. and Cherry, S.R. (1993) MRI-PET registration with automated algorithm, J. Comput. Assisted Tomogr. 17, 536-546
9. 14C]deoxyglucose method for the measurement of local glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat, J. Neurochem. 28, 897-916
10. Phelps, M.E. et al. (1979) Tomographic measurement of local glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method, Ann. Neurol. 6, 371-388
11. Hamberg, L.M. et al. (1994) The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?, J. Nucl. Med. 35, 1308-1312
12. Keyes, J.W. (1995) SUV: standard uptake or silly useless value?, J. Nucl. Med. 36, 1836-1839
13. Phillips, R.L., Chen, C.Y., Wong, D.F. and London, E.D. (1995) An improved method to calculate cerebral metabolic rates of glucose using PET, J. Nucl. Med. 36, 1668-1679
14. Hunter, G.J. et al. (1996) Simplified measurement of deoxyglucose utilization rate, J. Nucl Med. 37, 950-955
15. 18F] fluorodeoxyglucose and positron emission tomography, Neurology 32, 1323-1329
16. Wagner, H.N. and Conti, P.S. (1991) Advances in medical imaging for cancer diagnosis and treatment, Cancer 67, 1121-1128
17. Hussein, M.A-D., Scott, A., Macapinlac, H. and Larson, S. (1994) Tracer imaging in lung cancer, Eur. J. Nucl. Med. 21, 57-81
18. Francavilla, T.L., Miletch, R.S., Di Chiro, G. and Patronas, N.J. (1989) Positron emission tomography in the detection of malignant degeneration of low-grade gliomas, Neurosurgery 24, 1-5
19. 18F]fluorodeoxyglucose positron emission tomography, Ann. Neurol. 29, 347-355
20. 18F]fluoro-D-glucose in liver metastasis from colon carcinoma, J. Nucl. Med. 23, 1133-1137
21. 18F]fluorodeoxyglucose and positron emission tomography, J. Comput. Assisted Tomogr. 13, 1097-1098
22. Strauss, L.G. et al. (1989) Recurrence of colorectal tumors: PET evaluation, Radiology 170, 329-332
23. 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer, Int. J. Radiat. Oncol. Biol. Phys. 19, 1005-1010
24. Wahl, R.L., Cody, R.L., Hutchins, G.D. and Mudgett, E.E. (1991) Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue, Radiology 179, 765-770
25. Gupta, N.C. et al. (1992) Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose, Radiology 184, 441-444
26. Okada, J. et al. (1992) Positron emission tomography using fluorine-18 fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity, J. Nucl. Med. 33, 325-329
27. Fischman, A.J. and Alpert, N.M. (1993) FDG-PET in oncology: there's more to it than looking at pictures, J. Nucl. Med. 34, 6-11
28. Kubota, R. et al. (1995) Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG, J. Nucl. Med. 36, 484-492
29. Mineura, K. et al. (1991) Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography, J. Nucl. Med. 32, 726-728
30. Tilsley, D.W.O. et al. (1993) New techniques in the pharmacokinetic analysis of cancer drugs IV: positron emission tomography, Cancer Surv. 17, 425-442
31. 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer, Lancet 344, 1265-1266
32. Wagner, H.N. (1995) A new era of certainty. Newsline, J. Nucl. Med. 36, 13N-28N